Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.248
Filter
1.
Acta Academiae Medicinae Sinicae ; (6): 227-234, 2023.
Article in Chinese | WPRIM | ID: wpr-981257

ABSTRACT

Objective To investigate the treatment outcomes,prognosis,and risk factors of treatment failure of peritoneal dialysis associated peritonitis (PDAP) caused by Klebsiella pneumoniae,and thus provide clinical evidence for the prevention and treatment of this disease. Methods The clinical data of PDAP patients at four peritoneal dialysis centers from January 1,2014 to December 31,2019 were collected retrospectively.The treatment outcomes and prognosis were compared between the patients with PDAP caused by Klebsiella.pneumoniae and that caused by Escherichia coli.Kaplan-Meier method was employed to establish the survival curve of technical failure,and multivariate Logistic regression to analyze the risk factors of the treatment failure of PADP caused by Klebsiella pneumoniae. Results In the 4 peritoneal dialysis centers,1034 cases of PDAP occurred in 586 patients from 2014 to 2019,including 21 cases caused by Klebsiella pneumoniae and 98 cases caused by Escherichia coli.The incidence of Klebsiella pneumoniae caused PDAP was 0.0048 times per patient per year on average,ranging from 0.0024 to 0.0124 times per patient per year during 2014-2019.According to the Kaplan-Meier survival curve,the technical failure rate of Klebsiella pneumoniae caused PDAP was higher than that of Escherichia coli caused PDAP (P=0.022).The multivariate Logistic regression model showed that long-term dialysis was an independent risk factor for the treatment failure of Klebsiella pneumoniae caused PDAP (OR=1.082,95%CI=1.011-1.158,P=0.023).Klebsiella pneumoniae was highly sensitive to amikacin,meropenem,imipenem,piperacillin,and cefotetan,and it was highly resistant to ampicillin (81.82%),cefazolin (53.33%),tetracycline (50.00%),cefotaxime (43.75%),and chloramphenicol (42.86%). Conclusion The PDAP caused by Klebsiella pneumoniae had worse prognosis than that caused by Escherichia coli,and long-term dialysis was an independent risk factor for the treatment failure of Klebsiella pneumoniae caused PDAP.


Subject(s)
Humans , Klebsiella pneumoniae , Retrospective Studies , Anti-Bacterial Agents/therapeutic use , Peritoneal Dialysis/adverse effects , Peritonitis/drug therapy , Risk Factors , Treatment Failure , Escherichia coli
2.
Rev. bras. oftalmol ; 82: e0035, 2023. tab
Article in English | LILACS | ID: biblio-1449772

ABSTRACT

ABSTRACT Objective To assess pre-operative conditions that could influence primary anatomical success rate in a cohort of patients with rhegmatogenous retinal detachments (RRD) treated with primary vitrectomy and no scleral buckling. Methods A retrospective analysis was performed in a group of patients that underwent primary pars plana vitrectomy with gas tamponade and without scleral buckling for RRD between 2014 and 2019, with a minimum follow-up of 4 months. Results 305 eyes of 301 patients were included; 59.01% eyes were phakic, 39.01% were pseudophakic and 1.96% aphakic. 13.11% of patients had proliferative vitreoretinopathy grade B and 3.28% proliferative vitreoretinopathy grade C at the time of diagnosis while 83.61% had proliferative vitreoretinopathy grade 0 or A. 53.1% had superior breaks, 15.4% inferior breaks and 31.5% a combination of both. Primary success rate was obtained in 90.82% of eyes (95%CI 87.58-94.06). 9.18% of eyes (95%CI 5.94-12.42) re-detached. In 3.27% the cause of re-detachment was proliferative vitreoretinopathy, and in the remaining 5.90% because of a new or a missed break, the leakage of a previously treated break, or an area of shallow peripheral detachment with no detectable break. Of 181 phakic eyes, 10.49% re-detached, whereas in over 126 aphakic or pseudophakic eyes 7.75% re-detached (p=0.42). 16.39% eyes of the entire cohort had preoperative grade B or C proliferative vitreoretinopathy, whereas 32.14% of re-detached eyes had preoperative grade B or C proliferative vitreoretinopathy (95%CI 17.29-46.99; p=0.02). Th eyes that re-detached after the first surgery had a mean of 2.5 (95%CI 1.86-3.13) retinal tears, against a mean of 1.87 (95%CI 1.73-2.00) retinal tears of those that did not re-detach after the first surgery (p=0.02). Conclusion We found location of breaks and lens status to be independent factors not related to a lower single operation success rate, whereas the number or size of breaks and preoperative proliferative vitreoretinopathy stages B or C were independent factors related to a higher likelihood of re-detachment.


RESUMO Objetivo Avaliar condições pré-operatórias que poderiam influenciar a taxa de sucesso anatômico primário em uma coorte de pacientes com descolamento de retina regmatogênico tratada com vitrectomia primária e sem introflexão escleral. Métodos Foi realizada uma análise retrospectiva em um grupo de pacientes submetidos a vitrectomia primária pars plana com tamponamento gasoso e sem introflexão escleral por desprendimento de retina regmatogênico entre os anos 2014 e 2019, com monitoramento mínimo de 4 meses. Resultados Foram incluídos 305 olhos de 301 pacientes; 59,01% dos olhos eram fáquicos, 39,01% eram pseudofáquicos, e 1,96% era afáquico; 13,11% dos pacientes tinham vitreorretinopatia proliferativa grau B, e 3,28%, vitreorretinopatia proliferativa grau C no momento do diagnóstico, enquanto 83,61% tinham vitreorretinopatia proliferativa grau 0 ou A; 53,1% tinham rasgaduras superiores; 15,4%, rasgaduras inferiores e 31,5%, uma combinação de ambas. A taxa de sucesso primário foi obtida em 90,82% dos olhos (IC95% 87,58-94,06); 9,18% dos olhos (IC95% 5,94-12,42) se redestacaram. Em 3,27%, a causa do redescolamento foi vitreorretinopatia proliferativa e, nos 5,90% restantes, por causa de uma ruptura nova ou perdida, o vazamento de uma ruptura previamente tratada, ou uma área de descolamento periférico superficial sem ruptura detectável. Dos 181 olhos fáticos, 10,49% redestacaram-se, enquanto em mais de 126 olhos afáquicos ou pseudofáquicos 7,75% redestacaram-se (p=0,42); 16,39% dos olhos de toda a coorte tinham vitreorretinopatia proliferativa pré-operatória grau B ou C, enquanto 32,14% dos olhos redescolados tinham vitreorretinopatia proliferativa pré-operatória grau B ou C (IC95% 17,29-46,99) (p=0,02). Os olhos que se redescolaram após a primeira cirurgia tiveram média de 2,5 (IC95% 1,86-3,13) lágrimas retinianas, contra uma média de 1,87 (IC95% 1,73-2,00) lágrima retiniana daqueles que não se redestacaram após a primeira cirurgia. (p=0,02). Conclusão A localização das rasgaduras e o status da lente são fatores independentes não relacionados a uma menor taxa de sucesso da operação, enquanto o número ou o tamanho das rasgaduras e estágios vitreorretinopatia proliferativa pré-operatórios B ou C foram fatores independentes relacionados a uma maior probabilidade de redescolamento.


Subject(s)
Humans , Male , Female , Vitrectomy , Retinal Detachment/surgery , Scleral Buckling , Retinal Detachment/etiology , Medical Records , Retrospective Studies , Risk Factors , Treatment Failure , Vitreoretinopathy, Proliferative
3.
Coluna/Columna ; 22(2): e268880, 2023. tab, graf
Article in English | LILACS | ID: biblio-1448036

ABSTRACT

ABSTRACT Objective: Evaluate the prognostic factors associated with therapeutic failure and recurrence in pyogenic spondylodiscitis (PS). Methods: A historical cohort study was conducted in a reference Brazilian hospital for locomotor system and neurodevelopmental diseases. All patients with PS treated between January 1999 and December 2018 and followed for at least one year were included. PS was defined based on clinical, laboratory, and radiological criteria. Microbiological data and clinical outcomes at the end of follow-up were also collected and analyzed. Results: Fifty patients (mean age 50.94 ± 15.84 years, men 76.00%) were included. After twelve months of follow-up, therapeutic failure was observed in 24.00% (n = 12) and recurrence in 18.00% (n = 09) patients. Among those who were cured, residual symptoms were found in 50.00% (19/38). No deaths were observed. After multivariate analysis, therapeutic failure was associated with the prescription of antibiotic therapy before culture results (p = 0.0153), spinal cord compression (p = 0.0053), and sensory deficits (p = 0.0341). Furthermore, recurrence was associated with previous nonspinal surgeries (p = 0.0350) and spinal cord compression (p = 0.0447). Conclusion: PS causes significant morbidity. The prognosis depends mainly on the clinical presentation at admission, especially when associated with spinal cord compression, which reinforces the importance of early diagnosis. Level of Evidence II; Prognostic Studies.


RESUMO: Objetivo: Avaliar os fatores prognósticos associados à falha terapêutica e à recorrência na espondilodiscite piogênica (EP). Métodos: Um estudo de coorte histórica foi conduzido em um hospital brasileiro de referência nas doenças do sistema locomotor e do neurodesenvolvimento. Todos os pacientes com EP tratados entre janeiro de 1999 e dezembro de 2018 e acompanhados por pelo menos um ano foram incluídos. A EP foi definida com base em critérios clínicos, laboratoriais e radiológicos. Dados microbiológicos e desfechos clínicos ao final do tempo de seguimento também foram coletados e analisados. Resultados: Cinquenta pacientes (idade média 50,94 ± 15,84 anos, homem 76,00%) foram incluídos. Depois de doze meses de seguimento, a falha terapêutica foi observada em 24,00% (n = 12) e a recorrência em 18,00% (n = 09) dos pacientes. Entre os que curaram, sintomas residuais foram constatados em 50,00% (19/38). Nenhuma morte foi observada. Após análise multivariada, a falha terapêutica foi associada à prescrição de antibioticoterapia antes dos resultados de cultura (p = 0,0153), compressão medular (p = 0,0053) e déficits sensoriais (p = 0,0341). Além disso, a recorrência esteve associada a cirurgias não espinhais prévias (p = 0,0350) e à compressão medular (p = 0,0447). Conclusão: A EP causa morbidade significativa. O prognóstico depende principalmente da apresentação clínica na admissão, especialmente da existência de compressão medular, o que reforça a importância do diagnóstico precoce. Nível de Evidência II; Estudos de Prognóstico.


RESUMEN: Objetivo: Evaluar los factores pronósticos asociados con el fracaso terapéutico y la recurrencia en la espondilodiscitis piógena (EP). Métodos: Se realizó un estudio de cohorte histórica en un hospital de referencia brasileño para enfermedades del aparato locomotor y del neurodesarrollo. Se incluyeron todos los pacientes con EP tratados entre enero de 1999 y diciembre de 2018 y seguidos durante al menos un año. La EP se definió en base a criterios clínicos, de laboratorio y radiológicos. También se recopilaron y analizaron los datos microbiológicos y los resultados clínicos al final del tiempo de seguimiento. Resultados: Se incluyeron 50 pacientes (edad media 50,94 ± 15,84 años, sexo masculino 76,00%). A los doce meses de seguimiento, se observó fracaso terapéutico en el 24,00% (n=12) y recurrencia en el 18,00% (n=09) de los pacientes. Entre los que se curaron, se encontraron síntomas residuales en el 50,00% (19/38). No se observaron muertes. Tras el análisis multivariante, el fracaso terapéutico se asoció a la prescripción de antibioticoterapia antes de los resultados del cultivo (p = 0,0153), compresión medular (p = 0,0053) y déficits sensitivos (p = 0,0341). Además, la recurrencia se asoció con cirugías previas no espinales (p = 0,0350) y compresión medular (p = 0,0447). Se incluyeron 50 pacientes (edad media 50,94 ± 15,84 años, sexo masculino 76,00%). A los doce meses de seguimiento, se observó fracaso terapéutico en el 24,00% (n=12) y recurrencia en el 18,00% (n=09) de los pacientes. Entre los que se curaron, se encontraron síntomas residuales en el 50,00% (19/38). No se observaron muertes. Tras el análisis multivariante, el fracaso terapéutico se asoció a la prescripción de antibioticoterapia antes de los resultados del cultivo (p = 0,0153), compresión medular (p = 0,0053) y déficits sensitivos (p = 0,0341). Además, la recurrencia se asoció con cirugías previas no espinales (p = 0,0350) y compresión medular (p = 0,0447). Conclusión: La EP causa una morbilidad significativa. El pronóstico depende principalmente de la presentación clínica al ingreso, especialmente de la existencia de compresión medular, lo que refuerza la importancia del diagnóstico precoz. Nivel de Evidencia II; Estudios de Pronóstico.


Subject(s)
Humans , Adult , Middle Aged , Treatment Failure
4.
Arch. argent. pediatr ; 120(2): 89-98, abril 2022. tab, ilus
Article in English, Spanish | BINACIS, LILACS | ID: biblio-1363662

ABSTRACT

Introducción: los beneficios de la ventilación asistida ajustada neuronalmente (NAVA) en los recién nacidos prematuros son inciertos. El objetivo de este estudio fue explorar si la NAVA no invasiva (NIV) era más beneficiosa para los recién nacidos prematuros que la presión positiva continua nasal (NCPAP). Diseño del estudio: metanálisis de tres ensayos clínicos: dos ensayos controlados aleatorizados y un estudio de grupos cruzados. Se comparó la NAVA-NIV con la NCPAP y se informó sobre el fracaso del tratamiento, la mortalidad y los eventos adversos como resultados principales. Resultados: tres estudios con 173 pacientes (89 recibieron NAVA-NIV) cumplieron los criterios de inclusión en este metanálisis. No se observaron diferencias en el fracaso del tratamiento entre la NAVA-NIV y la NCPAP (razón de riesgos [RR] = 1,09; intervalo de confianza [IC] del 95 % = 0,65-1,84; diferencia de riesgos = 0,02; IC95% = -0,10-0,14; I2 = 33 %; P = 0,23). De manera similar, no hubo diferencias en la mortalidad (RR = 1,52; IC95% = 0,51-4,52; no aplica heterogeneidad). En comparación con la NCPAP, la NAVA-NIV redujo significativamente el uso de cafeína (RR = 0,85; IC 95% = 0,74-0,98; I2 = 71 %; P = 0,03). Conclusiones: en comparación con la NCPAP, no hay evidencia suficiente para sacar una conclusión sobre los beneficios o daños de la NAVA-NIV en los recién nacidos prematuros. Los hallazgos de esta revisión deben confirmarse en ensayos clínicos con una metodología rigurosa y potencia adecuada


Introduction: The benefits of neurally adjusted ventilatory assist (NAVA) in preterm infants are unclear. This study aimed to explore if noninvasive NAVA is more beneficial for preterm infants than nasal continuous positive airway pressure (NCPAP). Study design: Meta-analysis was performed in three clinical trials comprising two randomized controlled trials and one crossover study. We compared NIV-NAVA and NCPAP and reported treatment failure, mortality, and adverse events as the primary outcomes. Results: Three studies including 173 patients (89 of whom underwent NIV-NAVA) were eligible for this meta-analysis. This review found no difference in treatment failure between NIV-NAVA and NCPAP (RR 1.09, 95% CI 0.65 to 1.84; RD 0.02, 95% CI -0.10-0.14; I2=33%, P=0.23). Similarly, there was no difference in mortality (RR 1.52, 95% CI 0.51-4.52, heterogeneity not applicable). Compared with NCPAP, NIV-NAVA significantly reduced the use of caffeine (RR 0.85, 95% CI 0.74-0.98, I2=71%, P=0.03). Conclusions: Compared with NCPAP, there is insufficient evidence to conclude on the benefits or harm of NIV-NAVA therapy for preterm infants. The findings of this review should be confirmed using methodologically rigorous and adequately powered clinical trials.


Subject(s)
Humans , Infant, Newborn , Interactive Ventilatory Support/adverse effects , Infant, Premature , Treatment Failure , Cross-Over Studies , Continuous Positive Airway Pressure/adverse effects
5.
Chinese Journal of Oncology ; (12): 219-227, 2022.
Article in Chinese | WPRIM | ID: wpr-935204

ABSTRACT

Non-small cell lung cancer (NSCLC) is one of the most severe malignant tumors worldwide. Lobectomy and systematic nodal dissection remain the standard treatment for stageⅠNSCLC. Stereotactic body radiotherapy (SBRT) has become the standard treatment for medically inoperable patients. Though the prognosis of stage Ⅰ NSCLC patients is generally good, there are still about 20% of patients with local recurrence and distant metastasis. There is significant heterogeneity in the prognosis and failure phenotype of patients, which cannot be precisely distinguished by the pathological TNM classification system. Identification of the risk factors for the prognosis of patients with stage Ⅰ NSCLC is a key step to realize the treatment from experience to precision. Screening the high-risk patients will facilitate to individually develop the adjuvant therapy strategy after surgery or SBRT and improve the overall curative effect. There are many factors that are significantly related to the prognosis of stage Ⅰ NSCLC including individual factors such as gender, age, and systemic inflammatory biomarkers; treatment-related factors such as the extent of surgical resection of the primary tumor and lymph nodes, the choice of different radiation rays, and different dose fractionation; and tumor-related factors such as imaging information, pathology information; and molecular biology information. This review will analyze the treatment failure phenotype and prognostic factors of stageⅠ NSCLC in various perspectives such as individual-, tumor- and treatment-related factors.


Subject(s)
Humans , Carcinoma, Non-Small-Cell Lung/surgery , Lung Neoplasms/pathology , Phenotype , Prognosis , Treatment Failure
6.
Journal of Southern Medical University ; (12): 546-553, 2022.
Article in Chinese | WPRIM | ID: wpr-936346

ABSTRACT

OBJECTIVE@#To develop and validate a risk prediction model of treatment failure in patients with peritoneal dialysis-associated peritonitis (PDAP).@*METHODS@#We retrospectively analyzed the data of patients undergoing peritoneal dialysis (PD) in 3 dialysis centers in Jilin Province who developed PDAP between January 1, 2013 and December 31, 2019. The data collected from the Second Hospital of Jilin University and Second Division of First Hospital of Jilin University) were used as the training dataset and those from Jilin Central Hospital as the validation dataset. We developed a nomogram for predicting treatment failure using a logistic regression model with backward elimination. The performance of the nomogram was assessed by analyzing the C-statistic and the calibration plots. We also plotted decision curves to evaluate the clinical efficacy of the nomogram.@*RESULTS@#A total of 977 episodes of PDAP were included in the analysis (625 episodes in the training dataset and 352 episodes in the validation dataset). During follow-up, 78 treatment failures occurred in the training dataset and 35 in the validation dataset. A multivariable logistic regression prediction model was established, and the predictors in the final nomogram model included serum albumin, peritoneal dialysate white cell count on day 5, PD duration, and type of causative organisms. The nomogram showed a good performance in predicting treatment failure, with a C-statistic of 0.827 (95% CI: 0.784-0.871) in the training dataset and of 0.825 (95% CI: 0.743-0.908) in the validation dataset. The nomogram also performed well in calibration in both the training and validation datasets.@*CONCLUSION@#The established nomogram has a good accuracy in estimating the risk of treatment failure in PDAP patients.


Subject(s)
Humans , Peritoneal Dialysis/adverse effects , Peritonitis/therapy , Retrospective Studies , Treatment Failure , Treatment Outcome
7.
Chinese Journal of Contemporary Pediatrics ; (12): 319-325, 2022.
Article in English | WPRIM | ID: wpr-928607

ABSTRACT

OBJECTIVES@#To systematically evaluate the efficacy and safety of bosentan in the treatment of persistent pulmonary hypertension of the newborn (PPHN).@*METHODS@#Chinese Journal Full-text Database, Weipu Database, Wanfang Data, China Biology Medicine disc, PubMed, Web of Science, Embase, and Cochrane Library were searched for literature on bosentan in the treatment of PPHN published up to August 31, 2021.@*RESULTS@#A total of 8 randomized controlled trials were included for Meta analysis. The results of the Meta analysis showed that compared with the control group, the bosentan treatment group had a significantly lower treatment failure rate (RR=0.23, P<0.001), a significantly greater reduction in pulmonary artery pressure [mean difference (MD)=-11.79, P<0.001)], significantly greater increases in oxygen partial pressure (MD=10.21, P=0.006) and blood oxygen saturation (MD=8.30, P<0.001), and a significantly shorter length of hospital stay (MD=-1.35, P<0.001). The descriptive analysis showed that the bosentan treatment group had a lower degree of tricuspid regurgitation than the control group after treatment. The main adverse reactions of bosentan treatment included abnormal liver function, anemia and edema. The results of subgroup analysis based on treatment regimen, research area, and drug dose were consistent with those before stratification.@*CONCLUSIONS@#Bosentan is effective in the treatment of PPHN. However, when using bosentan, attention should be paid to adverse reactions such as abnormal liver function.


Subject(s)
Humans , Infant, Newborn , Bosentan/therapeutic use , China , Hypertension, Pulmonary/drug therapy , Treatment Failure
8.
Int. j. morphol ; 40(4): 973-980, 2022. ilus, tab
Article in Spanish | LILACS | ID: biblio-1405254

ABSTRACT

RESUMEN: En condiciones normales, la mandíbula y sus estructuras anatómicas (dientes, musculatura, piel), son inervadas por los ramos de la tercera división del nervio trigémino (nervio mandibular), sin embargo, existen reportes que evidencian inervación suplementaria de los dientes inferiores y la zona del ángulo mandibular. Lo último podría ser responsable del fracaso del bloqueo nervioso con anestesia local. El objetivo principal de esta investigación fue revisar artículos que describen la participación de otros nervios como el milohioideo y los ramos superficiales del plexo cervical, los cuales pueden ingresar a la mandíbula a través de forámenes ubicados a lo largo de su arquitectura. Para esto, se realizó una revisión narrativa de la literatura científica, en inglés y español, desde el año 1971 hasta el año 2019, utilizando las plataformas digitales PubMed, EBSCO, Cochrane library, Scielo y Google Scholar, literatura gris y además de una búsqueda manual. Acorde a los resultados de la revisión, se confirma la existencia de fracasos de técnicas anestésicas mandibulares debido a la inervación accesoria de la mandíbula y de los dientes inferiores, donde los tres principales nervios revisados tienen incidencia en este postulado. Finalmente se plantea un orden de ejecución para realizar la infiltración de anestésico local en la mandíbula para lograr un bloqueo exitoso durante los procedimientos odontológicos que la requieran.


SUMMARY: Under normal conditions, the mandible and its anatomical structures (teeth, muscles, skin) are innervated by the branches of the third division of the trigeminal nerve (mandibular nerve), however, there are reports that show supplementary innervation of the lower teeth and the mandibular angle area. The latter could be responsible for the failure of the nerve block under local anesthesia. The main objective of this research; is to review articles that describe the participation of other nerves such as the mylohyoid nerve, and the superficial branches of the cervical plexus, which can enter the mandible through foramina located along its architecture. For this, a narrative review of the scientific literature was carried out, in English and Spanish, from 1971 to 2019, using the digital platforms PubMed, EBSCO, Cochrane library, Scielo and Google Scholar, gray literature and in addition to a search Handbook. According to the results of the review, the existence of the failures of the mandibular anesthetic techniques due to the accessory innervation of the mandible and the lower teeth is confirmed, where the three main nerves reviewed have an impact on this postulate. In conclusion, an order of execution is proposed to perform local anesthetic infiltration into the jaw to achieve a successful block during dental procedures that require it.


Subject(s)
Humans , Mandible/innervation , Mandibular Nerve/anatomy & histology , Treatment Failure , Anesthesia, Dental
9.
Rev. bras. ginecol. obstet ; 43(4): 304-310, Apr. 2021. graf
Article in English | LILACS | ID: biblio-1280037

ABSTRACT

Abstract Hydrosalpinx is a disease characterized by the obstruction of the salpinx, with progressive accumulation in the shape of a fluid-filled sac at the distal part of the tuba uterina, and closed to the ovary. Women with hydrosalpinges have lower implantation and pregnancy rates due to a combination of mechanical and chemical factors thought to disrupt the endometrial environment. Evidence suggests that the presence of hydrosalpinx reduces the rate of pregnancy with assisted reproductive technology. The main aim of the present is review to make an overview of the possible effects of hydrosalpinx on in vitro fertilization (IVF).We conducted a literature search on the PubMed, Ovid MEDLINE, and Google Scholar data bases regarding hydrosalpinx and IVF outcomes. Hydrosalpinx probably has a direct toxic effect on sperm motility and on the embryos. In addition, the increasing liquid inside the salpinges could alter the mechanisms of endometrial receptivity. The window of endometrial receptivity is essential in the implantation of blastocysts, and it triggers multiple reactions arising from the endometrium as well as the blastocysts. Hydrosalpinx could influence the expression of homeobox A10 (HOXA10) gene, which plays an essential role in directing embryonic development and implantation. Salpingectomy restores the endometrial expression of HOXA10; therefore, it may be one mechanism by which tubal


Subject(s)
Humans , Female , Pregnancy , Embryo Implantation , Fertilization in Vitro , Treatment Failure , Fallopian Tube Diseases/complications , Salpingectomy , Infertility, Female/therapy , Blastocyst/physiology , Gene Expression , Endometrium/physiopathology , Fallopian Tube Diseases/surgery , Fallopian Tube Diseases/physiopathology , Homeobox A10 Proteins/genetics , Infertility, Female/etiology
10.
RFO UPF ; 26(1): 93-99, 20210327. ilus
Article in Portuguese | LILACS, BBO | ID: biblio-1428592

ABSTRACT

Objetivo: descrever um caso clínico em que a tomografia computadorizada de feixe cônico (TCFC) foi utilizada para auxiliar no diagnóstico e no melhor gerenciamento de retratamento endodôntico. Relato de caso: uma paciente compareceu à clínica com queixa de uma fístula na região dos molares superiores do lado direito há aproximadamente dois meses. Radiograficamente, observou-se lesão periapical do elemento 17. Após a confirmação da necessidade do retratamento, a paciente relatou já ter feito duas intervenções endodônticas nesse elemento. Assim, optou-se por solicitar um exame de TCFC, para melhores diagnóstico e planejamento do caso. Ao avaliar a TCFC, verificou-se presença de lesão periapical extensa, presença de espaços vazios no canal mesiovestibular (MV) e palatino (P), cone de guta percha além do ápice no canal distovestibular (DV) e localização do canal mesiopalatino (MP), que não havia sido manuseado anteriormente, rompimento de cortical óssea vestibular e palatino. Após planejamento, a paciente foi submetida ao retratamento endodôntico. Foi realizada a desobstrução dos canais radiculares com remoção do cone ultrapassando no canal DV, localização do MP e instrumentação completa de todos os canais. O hidróxido de cálcio foi utilizado como medicamento intracanal entre as consultas. Ao observar a regressão da fistula e os canais sem presença de exsudato, realizou-se a obturação do canal radicular. Considerações finais: a TCFC permitiu a visualização de erros operatórios pertinentes ao caso durante os tratamentos endodônticos prévios, o que possibilitou a indicação de um novo tratamento endodôntico e a manutenção do dente na arcada dentária.(AU)


Objective: to describe a clinical case where cone beam computed tomography (CBCT) was used to assist in the diagnosis and better management of endodontic retreatment. Case report: the patient attended the clinic complaining of a fistula in the upper molar region on the right side for approximately two months. Radiographically, the presence of a periapical lesion of element 17 was observed. After confirming the need for retreatment, the patient reported having already undergone two endodontic interventions on this tooth. Thus, it was decided to request a CBCT exam for better diagnosis and case planning. When assessing the CBCT, there was the presence of extensive periapical lesion, presence of empty spaces in the mesiobuccal (MB) and palatal (P) canal, gutta percha cone beyond the apex in the distobuccal (DB) canal and location of the mesiopalatal (MP) canal - which had not been previously handled -, rupture of the cortex vestibular and palatal bone. After planning, the patient underwent endodontic retreatment. Then, all the previous filling material were removed, including the gutta-percha by passing into the DB canal, MP was localized and complete instrumentation of all root canals were done. Calcium hydroxide was used as an intracanal medication between appointments. When the regression of the fistula was observed and canals were without exudate, root canal filling was performed. Final considerations: the CBCT allowed the visualization of operative errors pertinent to the case during previous endodontic treatments, which allowed the indication of a new endodontic treatment and the maintenance of the tooth in the dental arch.(AU)


Subject(s)
Humans , Female , Middle Aged , Root Canal Therapy/methods , Treatment Failure , Dental Pulp Cavity/diagnostic imaging , Radiography, Dental/methods , Treatment Outcome , Retreatment/methods , Cone-Beam Computed Tomography
11.
J. coloproctol. (Rio J., Impr.) ; 41(1): 42-46, Jan.-Mar. 2021. tab
Article in English | LILACS | ID: biblio-1286973

ABSTRACT

Abstract Introduction Colorectal cancer is the second most common type of cancer and the third leading cause ofmortality due to cancers. Anastomosis leak after proctectomy is a dangerous complication that must be managed carefully. The aim of the present study was to assess the procedure of resection and pull-through of the new rectum after anastomosis leak in patients after proctectomy. Methods and Materials This was a cross-sectional study. Patients who visited the Firoozgar Hospital between 2015 and 2018 for rectal cancer surgery and had anastomosis leak entered the study. All patients underwent resection of the residue of rectum and pull-through of colon. Results In the present study, out of the 110 cases who underwent proctectomy, 12 patients with postoperative anastomosis leak were reported. Five (41.7%) were male and 7 (58.3%) were female. Themean age of the patients was 41.5 ± 4.3 years (33-51). Resection of the new rectum and pull-through anastomosis were performed for these 12 patients. No major intraoperative complication occurred. Postoperative course was uneventful in all patients. Discussion Resection of residue of rectum and pull-through in patients with anastomosis leak can be done after rectal cancer surgery. This method is superior to abdominopelvic resection in many aspects, especially regarding accessibility to the new rectum by rectal exam or endosonography to assess recurrence or a relative continence after closure of ostomy.


Resumo Introdução O câncer colorretal é o segundo tipo de câncer mais comum, e a terceira principal causa de mortalidade por câncer. O vazamento da anastomose após a proctectomia é uma complicação perigosa, que deve ser tratada com cuidado. O objetivo do presente estudo foi avaliar o procedimento de ressecção e abaixamento do novo reto após vazamento de anastomose em pacientes submetidos à proctectomia. Métodos e Materiais Este foi um estudo transversal que incluiu pacientes que compareceram ao Firoozgar Hospital entre 2015 e 2018 submetidos a cirurgia de câncer retal e com vazamento de anastomose. Todos os pacientes foram submetidos a ressecção do resíduo do reto e abaixamento do cólon. Resultados No presente estudo, dos 110 casos submetidos a proctectomia, 12 pacientes tiveram vazamento de anastomose pós-operatório: 5 (41,7%) do sexo masculino e 7 (58,3%) do sexo feminino. A idade média dos pacientes foi de 41,5 ± 4,3 anos (gama: 33 a 51 anos). A ressecção do reto novo e a anastomose por abaixamento foram realizadas nesses 12 pacientes. Nenhuma complicação intraoperatória mais grave ocorreu. No pós-operatório, não houve intercorrências em nenhum dos pacientes. Discussão A ressecção de resíduo retal e o abaixamento em pacientes com vazamento de anastomose pode ser feita após cirurgia de câncer retal. Este método é superior à ressecção abdominopélvica em muitos aspectos, especialmente quanto à acessibilidade ao novo reto por exame retal ou endossonografia para avaliar a recorrência ou uma continência relativa após o fechamento da ostomia.


Subject(s)
Humans , Male , Female , Adult , Rectum/surgery , Treatment Failure , Colon/surgery , Proctectomy/adverse effects , Rectal Neoplasms/complications , Anastomosis, Surgical , Cross-Sectional Studies
12.
Journal of Experimental Hematology ; (6): 661-668, 2021.
Article in Chinese | WPRIM | ID: wpr-880130

ABSTRACT

OBJECTIVE@#To analyze the efficacy of CCLG-ALL-2008 protocol and the related factors of treatment failure in children with acute lymphoblastic leukemia (ALL).@*METHODS@#The clinical data of 400 children newly-diagnosed ALL in Children's Hospital of Soochow University from March 1, 2008 to December 31, 2012 was retrospectively analyzed. All the children accepted CCLG-ALL-2008 protocol, and were followed-up until October 2019. The dates of relapse, death and causes of death were recorded. Treatment failure was defined as relapse, non-relapse death, and secondary tumor.@*RESULTS@#Following-up for 10 years, there were 152 cases relapse or non-relapse death, the treatment failure rate was 38%, including 122 relapse (80.3%), 30 non-relapse deaths (19.7%) which included 7 cases (4 cases died of infection and 3 cases died of bleeding) died of treatment (23.3% of non-relapse deaths), 8 cases died of minimal residual disease (MRD) continuous positive (26.7% of non-relapse deaths) and 15 cases died of financial burden (50% of non-relapse deaths). According to the relapse stage, 37 cases (30%) in very early stage, 38 cases (31%) in early stage, and 47 cases (39%) in late stage, while according to the relapse site, 107 cases relapsed in bone marrow, 3 cases in testis, 3 cases in central nervous system (CNS), 5 cases in bone marrow plus testis and 4 cases in bone marrow plus CNS. Bone marrow relapse was the main cause of death in 89 cases, followed by nervous system. Initially diagnosed WBC count (≥50×10@*CONCLUSION@#Relapse is the main cause of treatment failure in children with ALL. The initially diagnosed WBC count, immunophenotype and MRD at week 12 were the independent prognostic factors for relapse of the patients. Financial burden accounts for a large proportion of non-relapse death.


Subject(s)
Child , Humans , Male , Antineoplastic Combined Chemotherapy Protocols , Disease-Free Survival , Neoplasm, Residual , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Prognosis , Recurrence , Retrospective Studies , Treatment Failure , Treatment Outcome
13.
Araçatuba; s.n; 2021. 42 p. tab, graf.
Thesis in Portuguese | LILACS, BBO | ID: biblio-1442628

ABSTRACT

O objetivo deste estudo foi relacionar a hipertensão e medicamentos antihipertensivos com o insucesso dos implantes osseointegrados. Foram analisados dados de 602 prontuários de pacientes que receberam tratamento reabilitador com implantes ossseointegrados no período de 2000 a 2017, concluído no mínimo há 6 meses. Foram coletados dados de idade, gênero, presença ou não de hipertensão, uso ou não antihipertensivos, número de implantes instalados e perdidos e tipo de prótese confeccionada. Testes estatísticos de qui-quadrado e teste exato de Fisher foram utilizados para relacionar as variáveis com a perda de implante, com nível de significância de p< 0,05. Foram instalados 1887 implantes com índice de sucesso de 97,51%(47 implantes perdidos em 41 pacientes). Dos 602 pacientes, 71,43 %(432) não apresentavam hipertensão e 28,36% (171) eram hipertensos. A taxa de sucesso dos implantes no grupo de normotensos foi de 93,28% e no grupo de hipertensos foi de 92,99%, não havendo diferença estatística entre eles (P= 0,958). Destes pacientes, as taxas de sucesso foram semelhantes para usuários de medicação (92,5%) e para não usuários (94,1%), não havendo diferença estatística relevante (P= 0,939). A presença da hipertensão, assim como o uso de antihipertensivos não puderam ser associadas ao insucesso dos implantes osseointegrados(AU)


The aim of this study was to relate hypertension and antihypertensive drugs to the failure of osseointegrated implants. Were analyzed 602 medical records of patients who received rehabilitation treatment with osseointegrated implants between 2000 and 2017, completed at least 6 months ago. Age, gender, presence or absence of hypertension, use or not antihypertensive drugs, number of installed and lost implants and type of prosthesis made were collected. Statistical chi-square tests and Fisher's exact test were used to relate the variables with implant loss, with a significance level of p < 0.05. 1,887 implants were installed with a success rate of 97.51% (47 implants lost in 41 patients). Of the 602 patients, 71.43% (432) did not have hypertension and 28.36% (171) were hypertensive. The success rate of implants in the normotensive group was 93.28% and in the hypertensive group it was 92.99%, with no statistical difference between them (P = 0.958). Of these patients, the success rates were similar for medication users (92.5%) and for non-users (94.1%), with no statistically significant difference (P = 0.939). The presence of hypertension, as well as the use of antihypertensives, could not be associated with the failure of osseointegrated implants(AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Treatment Failure , Dental Implantation, Endosseous , Dental Implants , Hypertension
14.
Braz. J. Pharm. Sci. (Online) ; 57: e19036, 2021. tab, graf
Article in English | LILACS | ID: biblio-1345453

ABSTRACT

Sub-therapeutic doses, shorter duration of therapy, female gender, bacteremia, and renal impairment were among independent predictors of polymyxin B treatment failure. In this study, we found an association between inappropriate doses of polymyxin B (<15000 or >25000 unit/kg/day) and renal impairment. Inappropriate doses of polymyxin B were significantly associated with CrCl 20-50 mL/min (p = 0.021, ORadj 6.660, 95% CI 1.326, 33.453) and CrCl <20 mL/min (p = 0.001, ORadj 22.200, 95% CI 3.481, 141.592). By conducting sub-group analysis only using subjects with appropriate dosage, renal impairment was not associated with polymyxin B treatment failure, thus indicating that treatment failure was due to an inappropriate dose of polymyxin B, rather than renal impairment. In conclusion, renal impairment was not directly associated with treatment failure but was due to an inappropriate dosage of polymyxin B after renal adjustment


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Polymyxin B/administration & dosage , Treatment Failure , Dosage/adverse effects , Therapeutics , Adaptation, Psychological , Bacteremia , Renal Insufficiency/drug therapy
15.
Rev. méd. Minas Gerais ; 31: 31108, 2021.
Article in English, Portuguese | LILACS | ID: biblio-1291264

ABSTRACT

Objetivo: Comparar o sucesso do tratamento não operatório da lesão esplênica contusa graus III e IV, antes e após a introdução da angioembolização como método adjuvante. Métodos: Os dados foram coletados do prontuário eletrônico de pacientes com lesões esplênicas contusas graus III e IV (exceto hematoma subcapsular), segundo classificação da AAST (American Association for Surgery of Trauma), submetidos ao tratamento não operatório no Hospital João XXIII no período de janeiro/2014 a julho/2017. Os dados foram comparados a uma série de casos dessas mesmas lesões entre novembro/2004 e dezembro/2013 na mesma instituição, quando a angioembolização não era utilizada. O nível de significância do estudo foi 5% e seu desfecho foi a falha do tratamento não operatório. As análises foram feitas nos software R3.6.3 e MINITAB versão 14. Resultados: Entre novembro/2004 e dezembro/2013, foram estudados 389 pacientes em tratamento conservador, sendo 332 (82,8%) com lesão esplênica contusa grau III e 67 (17,2%) grau IV, havendo falha no tratamento (necessidade de esplenectomia) em 36 (11%) com lesão grau III e 22 (33%) com lesão grau IV. No período de janeiro/2014 a julho/2017, quando da disponibilidade da angioembolização, 195 pacientes foram submetidos a tratamento conservador, sendo 110 (56,4%) com lesão esplênica contusa grau III e 85 (43,6%) grau IV. Desses, houve falha no tratamento em 4 (3,6%) com lesão grau III e 6 (7%) com lesão grau IV. Conclusão: O tratamento não operatório do trauma esplênico contuso associado à angioembolização apresentou redução, com significância estatística, da necessidade de esplenectomia nas lesões esplênicas graus III e IV.


Objective: Compare the success of non-operative treatment of blunt splenic injury grades III and IV, before and after the introduction of angioembolization. Methods: Data collected from electronic medical reports of patients presenting blunt splenic injury (BSI) grades III and IV (subcapsular hematoma was not included), according to AAST (American Association for Surgery of Trauma) classification and undergoing nonoperative management at Hospital João XXII from January 2014 to July 2017. Data was compared to a case series of these nonoperative injuries from November 2004 to December 2013 at the same institution, when angioembolization was not used. The study level of significance was 5% and outcome was failure of non-operative treatment. Analyses were made using the software R3.6.3 and MINITAB version 14. Results: From November/2004 to December/2013, 389 patients undergoing conservative treatment were studied, 332 (82,8%) of which presented with blunt splenic injury grade III and 67 (17,2%) had lesions grade IV, treatment failure (need for splenectomy) occurred in 36 (11%) patients with injury grade III and 22 (33%) with grade IV. From January/2014 to July/2017, when angioembolization was available, 195 patients underwent conservative treatment, 110 (56,4%) with blunt splenic injury grade III and 85 (43,6%) with grade IV. In this group, treatment failed in 4 (3,6%) with injury grade III and 6 (7%) grade IV. Conclusion: Nonoperative management of blunt splenic trauma associated with angioembolization is associated with a reduction in splenectomy in splenic injuries grades III and IV.


Subject(s)
Humans , Male , Female , Splenic Diseases , Embolization, Therapeutic , Spleen , Splenectomy , Therapeutics/methods , Wounds and Injuries , Angiography , Treatment Failure
16.
Femina ; 49(6): 379-384, 2021.
Article in Portuguese | LILACS | ID: biblio-1290571

ABSTRACT

O objetivo deste trabalho foi analisar os aspectos emocionais presentes no processo de reprodução humana assistida (RHA), por meio de uma revisão interativa da literatura. As bases de dados utilizadas foram PubMed, BVS e Periódicos Capes, com os descritores "infertility" AND "reproductive techniques" AND "emotions". Foram incluídos e analisados 24 artigos dos últimos cinco anos (2015 a 2020). Os resultados indicam que existem diversos sentimentos negativos que permeiam os casais infé rteis, especialmente quando existem falhas no tratamento. O apoio social durante o tratamento em RHA melhora a qualidade de vida do casal e diminui o sofrimento emocional. As estratégias de enfrentamento utilizadas pelos casais inférteis e as intervenções terapêuticas também foram avaliadas como positivas para o manejo do estresse, da ansiedade e da depressão. As diferenças de gênero apareceram nos estudos e reiteram a relevância das relações de gênero, indicando a necessidade de intervenções diferentes para homens e mulheres.(AU)


The aim of this work was to analyze the emotional aspects present in the assisted human reproduction (RHA) process, through an interactive literature review. The databases used were PUBMED, BVS and CAPES journals, with the descriptors "infertility" AND « reproductive techniques" AND "emotions." 24 articles from the last five years (2015 to 2020) were included and analyzed. The results indicate that there are several negative feelings that permeate infertile couples, especially when treatment failures, social support during RHA treatment improves the couple's quality of life and reduces emotional distress. The coping strategies used by infertile couples and interventions therapeutics were also evaluated as positive for the management of stress, anxiety and depression. The gender differences appeared in the studies and reiterate the relevance of gender relations, indicating the need for different interventions for men and women.(AU)


Subject(s)
Humans , Male , Female , Reproductive Techniques, Assisted/psychology , Psychological Distress , Infertility/psychology , Infertility/therapy , Social Support , Adaptation, Psychological , Databases, Bibliographic , Treatment Outcome , Treatment Failure
18.
Rev. Pesqui. (Univ. Fed. Estado Rio J., Online) ; 13: 1142-1147, jan.-dez. 2021. tab
Article in English, Portuguese | LILACS, BDENF | ID: biblio-1255126

ABSTRACT

Objetivo: Descrever características demográficas, clínicas, da terapia intravenosa prévia e cateterização intravenosa periférica em crianças com câncer e insucesso do procedimento. Método: trata-se de um estudo descritivo do tipo transversal, realizado com 18 crianças com insucesso da punção intravenosa periférica, internadas na clínica oncológica pediátrica do Hospital Estadual da Criança, em Feira de Santana-Bahia, entre Abril de 2015 e Dezembro de 2016. Resultados:evidenciou-se o insucesso em 11,7% das crianças. A maioria tinha 01 a 49 meses, pardas, sexo masculino, eutróficas, e o principal motivo de insucesso foi transfixação da veia. Os fatores predisponentes relativos ao insucesso foram história de dificuldade de inserção de cateter intravenoso periférico, complicação anterior à terapia intravenosa, internação anterior e antecedente de infiltração. Conclusão: o percentual de insucesso da punção intravenosa periférica é semelhante aos valores encontrados em estudos sobre o contexto, relacionado com o perfil das crianças, a terapia utilizada, e os fatores predisponentes


Objective:To describe demographic, clinical, prior intravenous therapy and peripheral intravenous catheterization characteristics in children with cancer and procedural failure. Method: this is a cross-sectional descriptive study of 18 children with peripheral intravenous puncture failure hospitalized at the pediatric oncology clinic of Hospital Estadual da Criança, in Feira de Santana-Bahia, between April 2015 and December 2016 Results: failure was observed in 11.7% of the children. The majority were 01 to 49 months, brown, male, eutrophic, and the main reason for failure was transfixation of the vein. The predisposing factors related to failure were a history of difficulty in insertion of a peripheral intravenous catheter, a complication prior to intravenous therapy, previous hospitalization and previous infiltration. Conclusion:the percentage of failure of the peripheral intravenous puncture is similar to the values found in studies on the context, related to the profile of the children, the therapy used, and the predisposing factors


Objetivo: Describir características demográficas, clínicas, de la terapia intravenosa previa y cateterización intravenosa periférica en niños con cáncer y fracaso del procedimiento. Método: se trata de un estudio descriptivo del tipo transversal, realizado con 18 niños con fracaso de la punción intravenosa periférica, internados en la clínica oncológica pediátrica del Hospital Estadual del Niño, en Feira de Santana-Bahía, entre abril de 2015 y diciembre de 2016. Resultados: se evidenció el fracaso en el 11,7% de los niños. La mayoría tenía entre 01 y 49 meses, pardas, sexo masculino, eutróficas, y el principal motivo de fracaso fue la transfixación de la vena. Los factores predisponentes relativos al fracaso fueron historia de dificultad de inserción de catéter intravenoso periférico, complicación anterior a la terapia intravenosa, internación anterior y antecedente de infiltración. Conclusión: el porcentaje de fracaso de la punción intravenosa periférica es similar a los valores encontrados en estudios sobre el contexto, relacionado con el perfil de los niños, la terapia utilizada, y los factores predisponentes


Subject(s)
Humans , Infant , Child, Preschool , Child , Adolescent , Infusions, Intravenous , Catheterization, Peripheral , Treatment Failure , Neoplasms/therapy , Cross-Sectional Studies , Patient Safety
20.
Rev. chil. infectol ; 37(5): 550-554, nov. 2020. tab, graf
Article in Spanish | LILACS | ID: biblio-1144249

ABSTRACT

Resumen Introducción: Cargas virales (CV) entre 20-200 copias/mL se consideran cargas virales de bajo grado (CVBG). Su implicancia clínica y manejo no han sido definidos. Objetivo: Evaluar el impacto de CVBG en el riesgo de desarrollo posterior de fallo virológico (FV). Pacientes y Métodos: Se incluyeron pacientes ≥ 18 años, desde enero de 2009 a diciembre de 2019, con infección por VIH-1 con CV< 20 copias/mL, por un mínimo de seis meses y/o en dos muestras consecutivas bajo tratamiento anti-retroviral . Se realizó seguimiento de las CV estrati ficándolas: CV < 20 copias/mL, CVBG (20-50 copias/mL y 51-200 copias/mL) y FV. Mediana de seguimiento 25 meses (IQR 15-31). Resultados: Fueron incluidos 1.416 pacientes con CV < 20 copias/ mL bajo TARV. De ellos, 797 permanecieron con CV< 20 copias/mL durante el seguimiento, 144 presentaron CV entre 20-50 copias/mL, 384 entre 51-200 copias/mL y 91 presentaron FV sin CVBG previa. De los 528 pacientes que tuvieron CVBG, 110 (20,1%) fallaron, riesgo 3,45 veces superior respecto a los que no tuvieron CVBG previa. El riesgo de FV fue 3,27 mayor para aquellos que tuvieron CVBG entre 51-200 copias/mL vs 20-50 copias/mL. Discusión: El estudio permite relacionar la CVBG con el FV posterior, siendo el mayor riesgo CVBG entre 51-200 copias/mL.


Abstract Background: Viral loads (VL) between 20-200 copies/mL are considered low-grade viral loads (LGVL). Its clinical implications and management have not been defined. Aim: To evaluate the impact of LGVL on the risk of subsequent development of virological failure (VF). Methods: Patients ≥ 18 years, with HIV-1 infection who had VL < 20 copies/mL for at least six months and/or in two consecutive samples under antiretroviral therapy (ART) were included, between January 1st, 2009 and December 31, 2019. Follow-up of the VLs was carried out stratifying them in VL < 20 copies/mL, LGVL (20-50 copies/mL and 51-200 copies/mL) and VF. Median follow-up 25 months (IQR 15-31). Results: 1,416 patients were included who reached VL < 20 copies/ml under ART, 797 patients remained with CV < 20 copies/mL during follow-up, 144 patients had VL between 21-50 copies/mL, 384 between 51-200 copies/mL and 91 had VF without previous LGVL. Out of 528 patients who had LGVL, 110 failed, risk 3.45 times higher than those who had no previous LGVL. Risk 3.27 times higher of VF for those who had LGVL between 51-200 copies/mL compared to 20-50 copies/mL. Discussion: The study allows to relate the LGVL with VF. This association was observed more frequently with LGVL between 51-200 copies/mL


Subject(s)
Humans , Viremia/etiology , HIV Infections/complications , HIV Infections/drug therapy , HIV-1 , Treatment Failure , Anti-HIV Agents/therapeutic use , Viral Load , Antiretroviral Therapy, Highly Active
SELECTION OF CITATIONS
SEARCH DETAIL